A Phase I, first-in-human trial of GSK2126458 (GSK458) in patients with advanced solid tumors.

Trial Profile

A Phase I, first-in-human trial of GSK2126458 (GSK458) in patients with advanced solid tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Dec 2015

At a glance

  • Drugs Omipalisib (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 07 Dec 2015 New trial record
    • 24 Nov 2015 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top